Sexual health for all?

Journal of Sexual Medicine

Volumn 8, Issue 8, 2011, Pages 2119-2121

  Giraldi, Annamaria ^a   Goldstein, Irwin ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; PROLACTIN; RISPERIDONE;

CORPUS CAVERNOSUM; DRUG WITHDRAWAL; EDITORIAL; EJACULATION DISORDER; ERECTILE DYSFUNCTION; HUMAN; PERINEUM INJURY; PEYRONIE DISEASE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX THERAPY; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SEXUAL HEALTH; TREATMENT WITHDRAWAL;

EID: 79960816680     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02398.x     Document Type: Editorial

References (13)

1. Acuna MJ, Martin JC, Graciani M, Cruces A, Gotor F. A comparative study of the sexual function of institutionalized patients with schizophrenia. J Sex Med 2010;7:3414-23.
2. Malik P, Kemmler G, Hummer M, Riecher-Roessler A, Kahn RS, Fleischhacker WW. Sexual dysfunction in first-episode schizophrenia patients: Results from European first episode schizophrenia trial. J Clin Psychopharmacol 2011;31:274-80.
3. Adrianzen C, Rango-Davila C, Araujo DM, Ruiz I, Walton RJ, Dossenbach M, Karagianis J. Relative association of treatment-emergent adverse events with quality of life of patients with schizophrenia: Post hoc analysis from a 3-year observational study. Hum Psychopharmacol 2010;25:439-47.
4. Pfaus JG. Pathways of sexual desire. J Sex Med 2009;6:1506-33.
5. Clayton AH. Epidemiology and neurobiology of female sexual dysfunction. J Sex Med 2007;4:S260-8.
6. Baggaley M. Sexual dysfunction in schizophrenia: Focus on recent evidence. Hum Psychopharmacol 2008;23:201-9.
7. Montejo AL. Prolactin awareness: An essential consideration for physical health in schizophrenia. Eur Neuropsychopharmacol 2008;18:S108-114.
8. Rettenbacher MA, Hofer A, Ebenbichler C, Baumgartner S, Edlinger M, Engl J, Kaser S, Kemmler G, Malik P, Tschoner A, Fleischhacker WW. Prolactin levels and sexual adverse effects in patients with schizophrenia during antipsychotic treatment. J Clin Psychopharmacol 2010;30:711-5.
9. Westheide J, Cvetanovska G, Albrecht C, Bliesener N, Cooper-Mahkorn D, Creutz C, Hornung WP, Klingmuller D, Lemke MR, Maier W, Schubert M, Strater B, Kuhn KU. Prolactin, subjective well-being and sexual dysfunction: An open label observational study comparing quetiapine with risperidone. J Sex Med 2008;5:2816-26.
10. Clayton AH, Montejo AL. Major depressive disorder, antidepressants, and sexual dysfunction. J Clin Psychiatry 2006;67:S33-7.
11. Montejo AL, Majadas S, Rico-Villademoros F, Llorca G, De GJ, Franco M, Martin-Carrasco M, Aguera L, Prieto N. Frequency of sexual dysfunction in patients with a psychotic disorder receiving antipsychotics. J Sex Med 2010;7:3404-13.
12. Montejo AL. The need for routine physical health care in schizophrenia. Eur Psychiatry 2010;25:S3-5.
13. De HM, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, Detraux J, Gautam S, Moller HJ, Ndetei DM, Newcomer JW, Uwakwe R, Leucht S. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 2011;10:52-77.